Effective 1 de noviembre de 2018, Transcatheter Mitral Valve Repair will require prior authorization for Commercial Products through the online authorization tool. The service will remain medically necessary for BlueCHiP for Medicare when performed as part of Centers for Medicare and Medicaid Services approved clinical trial. View this version of the policy.